adult patients with severe bacterial infections caused by organisms susceptible to imipenem and cefotaxime were given either imipenem/cilastatin sodium ( mk0787/mk0791 ) or cefotaxime as a part of a multiclinic randomized study to evaluate the effectiveness , safety , and tolerability of imipenem/cilastatin .
C0004623
bacterial infections
C0020933
imipenem